Clinical Trials Browser

Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06429800 2025-04-24

A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus Erythematosus

Phase 1 Withdrawn

Lupus Erythematosus, Systemic, Lupus Nephritis, Epstein-Barr Virus Infections

NCT05183490 2024-12-30

R-MVST Cells for Treatment of Viral Infections

Phase 1 Recruiting

36 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT06135922 2023-11-18

Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection

Phase 1 Recruiting

9 enrolled

Epstein-Barr Virus Infections

NCT01535885 2021-10-25

ACE

Phase 1 Completed

25 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT00058591 2020-01-18

SCAEBV

Phase 1 Completed

13 enrolled

Epstein-Barr Virus Infections

NCT00058604 2020-01-18

EUCLID

Phase 1 Completed

12 enrolled

Lymphoid

Lymphoproliferative Disorders, Epstein-Barr Virus Infections

NCT01800071 2018-07-17

A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma

Phase 1 Completed

22 enrolled

Head & Neck

Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT02761291 2016-05-16

Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma

Phase 1 Unknown

18 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence, Epstein-Barr Virus Infections, Multiple Acyl Coenzyme A Dehydrogenase Deficiency

NCT00706316 2015-07-10

NPC-CTL

Phase 1 Completed

5 enrolled

Head & Neck

Nasopharyngeal Neoplasms, Neoplasm Metastasis, Recurrence, Epstein-Barr Virus Infections

NCT00058812 2015-01-29

ETNA

Phase 1 Completed

69 enrolled

Epstein-Barr Virus Infections

NCT01070797 2014-09-04

VIRAGE

Phase 1 Completed

10 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT00078546 2012-07-30

CLANC

Phase 1 Completed

12 enrolled

Head & Neck

Carcinoma, Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT00779337 2012-05-22

EPL

Phase 1 Completed

8 enrolled

Lymphoid

Lymphoma, Epstein-Barr Virus Infections

NCT01147991 2012-02-28

Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer

Phase 1 Completed

16 enrolled

GastrointestinalHead & NeckLymphoid

Burkitt Lymphoma, Head and Neck Neoplasms, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoproliferative Disorders, Nasopharyngeal Neoplasms, Stomach Neoplasms, Lymphoma, Large-Cell, Immunoblastic, Epstein-Barr Virus Infections, Lymphoma, Extranodal NK-T-Cell

NCT01256853 2011-12-22

Modified Vaccinia Ankara (MVA) Vaccine Study

Phase 1 Completed

18 enrolled

Head & Neck

Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

Clinical Trials

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

Rituximab for PTLD Prevention in Solid Organ Transplant Recipients With EBV DNAemia

Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection

mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults

Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of Age

A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

CILESTE

A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants

TETRAVI

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection

DOTTI

A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus Erythematosus

R-MVST Cells for Treatment of Viral Infections

Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection

ACE

SCAEBV

EUCLID

A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma

Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma

NPC-CTL

ETNA

VIRAGE

CLANC

EPL

Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer

Modified Vaccinia Ankara (MVA) Vaccine Study